Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 2;25(15):8465.
doi: 10.3390/ijms25158465.

Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease

Linna Xu  1 , Qingqing Yang  1 , Jinghua Zhou  1
Affiliations
Review

Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease

Linna Xu et al. Int J Mol Sci. .

Abstract

Lipid metabolism is a critical component in preserving homeostasis and health, and lipids are significant chemicals involved in energy metabolism in living things. With the growing interest in lipid metabolism in recent years, an increasing number of studies have demonstrated the close relationship between abnormalities in lipid metabolism and the development of numerous human diseases, including cancer, cardiovascular, neurological, and endocrine system diseases. Thus, understanding how aberrant lipid metabolism contributes to the development of related diseases and how it works offers a theoretical foundation for treating and preventing related human diseases as well as new avenues for the targeted treatment of related diseases. Therefore, we discuss the processes of aberrant lipid metabolism in various human diseases in this review, including diseases of the cardiovascular system, neurodegenerative diseases, endocrine system diseases (such as obesity and type 2 diabetes mellitus), and other diseases including cancer.

Keywords: abnormal lipid metabolism; cancer; cardiovascular system diseases; endocrine system diseases; neurodegenerative diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mechanism of atherosclerosis caused by abnormal lipid metabolism.
Figure 2
Figure 2
Lipid metabolism disorders and various diseases.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Li Y., Ma Z., Jiang S., Hu W., Li T., Di S., Wang D., Yang Y. A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. Prog. Lipid Res. 2017;66:42–49. doi: 10.1016/j.plipres.2017.04.002. - DOI - PubMed
    1. Hoy A.J., Nagarajan S.R., Butler L.M. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat. Rev. Cancer. 2021;21:753–766. doi: 10.1038/s41568-021-00388-4. - DOI - PubMed
    1. Li Z., Guo H., Li J., Ma T., Zhou S., Zhang Z., Miao L., Cai L. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function. Clin. Sci. 2020;134:2469–2487. doi: 10.1042/CS20191088. - DOI - PubMed
    1. Balling M., Afzal S., Davey Smith G., Varbo A., Langsted A., Kamstrup P.R., Nordestgaard B.G. Elevated LDL triglycerides and atherosclerotic risk. J. Am. Coll. Cardiol. 2023;81:136–152. doi: 10.1016/j.jacc.2022.10.019. - DOI - PubMed
    1. Giral H., Kratzer A., Landmesser U. MicroRNAs in lipid metabolism and atherosclerosis. Best Pract. Res. Clin. Endocrinol. Metab. 2016;30:665–676. doi: 10.1016/j.beem.2016.11.010. - DOI - PubMed

MeSH terms

LinkOut - more resources